Amypopharma Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Amypopharma General Information
Description
Operator of a health technology company intended to offer treatment for nerve pathologies. The company develops functionalized nanoliposomes for therapeutic approaches to treat protein misfolding disorders, providing healthcare providers with a potential treatment for Alzheimer's disease.
Contact Information
Website
www.amypopharma.comCorporate Office
- Via Gioberti, 8
- 20123 Milan
- Italy
Corporate Office
- Via Gioberti, 8
- 20123 Milan
- Italy
Amypopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 04-Apr-2023 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 12-May-2018 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Generating Revenue |
Amypopharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amypopharma FAQs
-
When was Amypopharma founded?
Amypopharma was founded in 2015.
-
Where is Amypopharma headquartered?
Amypopharma is headquartered in Milan, Italy.
-
What industry is Amypopharma in?
Amypopharma’s primary industry is Biotechnology.
-
Is Amypopharma a private or public company?
Amypopharma is a Private company.
-
What is Amypopharma’s current revenue?
The current revenue for Amypopharma is .
-
How much funding has Amypopharma raised over time?
Amypopharma has raised $825K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
